Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Moving side chains amps up peptides' infection-fighting abilities

Aug. 25, 2021

Ascletis completes bridging study and opens Chinese phase II trial of ASC-42 for chronic hepatitis B

Aug. 25, 2021

EOM initiates phase I/IIa study of EOM-613 in hospitalized COVID-19 patients

Aug. 25, 2021

Engineered ACE2 protects against SARS-CoV-2 infection in vivo

Aug. 25, 2021

Suzhou Ark Biopharmaceutical patents respiratory syncytial virus inhibitors

Aug. 24, 2021

ACMT reports on patients becoming ill from use of ivermectin for COVID-19

Aug. 23, 2021

Salicylanilide compounds show promise for treating COVID-19

Aug. 23, 2021

KIN-001 for COVID-19 shows preclinical antiviral, anti-inflammatory and antifibrotic activity

Aug. 23, 2021

A virus-specific nanobody lowers latent viral loads in HCMV-infected cells

Aug. 23, 2021

Rare gene variants increase zoonotic H7N9 susceptibility

Aug. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...